Financement

Financeur: GILEAD SCIENCES, S.L.

1 financements - 49 997€

données disponibles depuis 2019

2019

Preclinical in vivo study of the role of the autocrine IL-10/JAK1/STAT3 cascade in the pro-survival signaling and anti-tumor immune evasion of diffuse large B-cell lymphomas
49 997,00